Collaborative Development
Licensable products
Q Chip is developing generic formulations of market- leading LA SR peptides and developing a first in class SR Interferon alpha 2a product. We are targeting abbreviated registration routes. Some of our products are available for licence.
Q Chip has signed four collaborative agreements during 2011.
Contract development
Q Chip can enable delivery of innovative SR formulations of small molecules, peptides and complex biotherapies on a collaborative basis. We work with biotechnology and pharmaceutical clients from formulation development through to clinical trials.
We are commissioning a cGMP aseptic manufacturing for the production of clinical trial material; this will be operational in 2012.
